[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000030625A3 - Use of phosphonoformic acid derivatives for treating infections - Google Patents

Use of phosphonoformic acid derivatives for treating infections Download PDF

Info

Publication number
WO2000030625A3
WO2000030625A3 PCT/EP1999/008965 EP9908965W WO0030625A3 WO 2000030625 A3 WO2000030625 A3 WO 2000030625A3 EP 9908965 W EP9908965 W EP 9908965W WO 0030625 A3 WO0030625 A3 WO 0030625A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid derivatives
treating infections
phosphonoformic acid
processes
compound
Prior art date
Application number
PCT/EP1999/008965
Other languages
German (de)
French (fr)
Other versions
WO2000030625A2 (en
Inventor
Hassan Jomaa
Original Assignee
Hassan Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EA200100586A priority Critical patent/EA200100586A1/en
Priority to JP2000583508A priority patent/JP2002530326A/en
Priority to CA002352549A priority patent/CA2352549A1/en
Priority to BR9915639-3A priority patent/BR9915639A/en
Priority to IL14277699A priority patent/IL142776A0/en
Priority to PL99348721A priority patent/PL348721A1/en
Application filed by Hassan Jomaa filed Critical Hassan Jomaa
Priority to AU15556/00A priority patent/AU1555600A/en
Priority to EP99958099A priority patent/EP1131075A2/en
Priority to APAP/P/2001/002165A priority patent/AP2001002165A0/en
Publication of WO2000030625A2 publication Critical patent/WO2000030625A2/en
Publication of WO2000030625A3 publication Critical patent/WO2000030625A3/en
Priority to NO20012541A priority patent/NO20012541L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to the use of a compound of formula (I) for the prophylaxis and therapy of infectious processes in humans and animals, which processes are induced by bacteria, fungi or parasites. The inventive compound is also used as fungicidal, bactericidal or herbicidal agent in plants.
PCT/EP1999/008965 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections WO2000030625A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2000583508A JP2002530326A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for the treatment of infectious diseases
CA002352549A CA2352549A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
BR9915639-3A BR9915639A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives to treat infections
IL14277699A IL142776A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
PL99348721A PL348721A1 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EA200100586A EA200100586A1 (en) 1998-11-25 1999-11-20 APPLICATION OF DERIVATIVES OF PHOSPHOROMAURIC ACID FOR THE TREATMENT OF INFECTIONS
AU15556/00A AU1555600A (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
EP99958099A EP1131075A2 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
APAP/P/2001/002165A AP2001002165A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections
NO20012541A NO20012541L (en) 1998-11-25 2001-05-23 Use of phosphonomauric acid derivatives for the treatment of infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854402A DE19854402A1 (en) 1998-11-25 1998-11-25 Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections
DE19854402.2 1998-11-25

Publications (2)

Publication Number Publication Date
WO2000030625A2 WO2000030625A2 (en) 2000-06-02
WO2000030625A3 true WO2000030625A3 (en) 2000-10-05

Family

ID=7888997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/008965 WO2000030625A2 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections

Country Status (16)

Country Link
EP (1) EP1131075A2 (en)
JP (1) JP2002530326A (en)
CN (1) CN1328465A (en)
AP (1) AP2001002165A0 (en)
AU (1) AU1555600A (en)
BR (1) BR9915639A (en)
CA (1) CA2352549A1 (en)
CZ (1) CZ20011821A3 (en)
DE (1) DE19854402A1 (en)
EA (1) EA200100586A1 (en)
IL (1) IL142776A0 (en)
NO (1) NO20012541L (en)
OA (1) OA11717A (en)
PL (1) PL348721A1 (en)
TR (1) TR200101433T2 (en)
WO (1) WO2000030625A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603542A1 (en) * 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof
CN105794493A (en) * 2016-03-11 2016-07-27 钦州市凤源泉生物科技有限公司 Culture method for improving main active components of russule
KR101797926B1 (en) * 2016-11-21 2017-11-15 한국식품연구원 Composition for preventing or treating obesity or obesity-realated metabolic syndrome comprising formic acid or pharmaceutically acceptable salt thereof as an active ingredient
KR101912774B1 (en) * 2016-11-21 2018-10-29 한국식품연구원 Composition comprising a strain having formic acid producing ability for the preventing or treatment of obesity, or obesity-realated metabolic syndrome
CN108948005A (en) * 2018-07-03 2018-12-07 湖南华腾制药有限公司 Polyethyleneglycol modified Enoxacin and application
KR102641583B1 (en) * 2018-10-23 2024-02-28 건국대학교 산학협력단 Composition for preventing plant diseases comprising zidovudine
CN114983999A (en) * 2022-06-09 2022-09-02 四川大学 New application and verification method of artemisinin and derivatives thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016537A1 (en) * 1996-10-11 1998-04-23 Astra Aktiebolag (Publ) Novel compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016537A1 (en) * 1996-10-11 1998-04-23 Astra Aktiebolag (Publ) Novel compounds

Also Published As

Publication number Publication date
AU1555600A (en) 2000-06-13
AP2001002165A0 (en) 2001-06-30
OA11717A (en) 2005-01-26
PL348721A1 (en) 2002-06-03
NO20012541D0 (en) 2001-05-23
TR200101433T2 (en) 2001-10-22
DE19854402A1 (en) 2000-05-31
EP1131075A2 (en) 2001-09-12
IL142776A0 (en) 2002-03-10
CN1328465A (en) 2001-12-26
BR9915639A (en) 2001-08-07
CZ20011821A3 (en) 2001-09-12
NO20012541L (en) 2001-07-24
WO2000030625A2 (en) 2000-06-02
JP2002530326A (en) 2002-09-17
EA200100586A1 (en) 2001-12-24
CA2352549A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
WO1999052515A3 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
RS24604A (en) Herbicides containing substituted thien- 3-yl-sulfonylamino (thio)carbonyl- triazolin(thi)one
WO2001028339A3 (en) Antimicrobial compositions comprising a biologically active organic acid
AR087990A2 (en) COMBINATIONS OF ACTIVE COMPOUNDS, METHOD TO CONTROL FUNGICIDES AND INSECTICIDES COMPOSITIONS, USE OF THESE COMBINATIONS OR COMPOSITIONS TO CONTROL FUNDS AND INSECTS, AND PROCEDURE FOR THE PREPARATION OF THESE COMPOSITIONS
DK0514768T3 (en)
AU1401692A (en) Biguanide derivatives, manufacturing method thereof and disinfectants containing the derivatives
YU2201A (en) Phosphorous organic compounds and their use
MXPA04000874A (en) Fungicidal composition and use of this composition for controlling plant diseases.
WO2000030625A3 (en) Use of phosphonoformic acid derivatives for treating infections
WO2000044359A3 (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
GT200200146A (en) NEW FUNGICIDE COMPOUNDS
MY131067A (en) Selective herbicides comprising a tetrazolinone derivative
MXPA04004557A (en) Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide derivative.
WO2000066094A3 (en) Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
AP2001002106A0 (en) Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide.
IS5956A (en) Use of bisphosphonic acid for the prevention and treatment of infection processes
WO2000030653A3 (en) Use of phosphonoformic acid derivatives for treating infections
WO2000044358A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
WO2003017766A3 (en) Herbicides made from substituted aryl ketones
WO1999063827A8 (en) Agricultural/horticultural bacterial disease injury-controlling agents
ATE146458T1 (en) INSECTICIDE AND ACARICIDE DIPHENYL CARBONITRILES AND DIARYLNITROPYRROL DERIVATIVES
NO20013464L (en) Use of 3-isoxazolidinones and hydroxylamino acids for the treatment of infections
WO2001092341A8 (en) Hexaglucal compound and the use and the methods of preparing them
WO2001049668A3 (en) 4-aryl-1-difluoromethoxyimidazoles and use thereof as herbicides
BRPI0415077A (en) fungicidal mixtures to combat rice pathogens, fungicidal agent, process to combat harmful fungi, seed, and use of compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99813703.0

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2000 15556

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 142776

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/00510/MU

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 15556/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PV2001-1821

Country of ref document: CZ

Ref document number: 2001/01433

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 2352549

Country of ref document: CA

Ref document number: 2352549

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 583508

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09856804

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: AP/P/2001/002165

Country of ref document: AP

WWE Wipo information: entry into national phase

Ref document number: 1999958099

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200100586

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1999958099

Country of ref document: EP

Ref document number: PV2001-1821

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: PV2001-1821

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1999958099

Country of ref document: EP